This is a Singapore news story, published by CNBC, that relates primarily to Femom news.
For more Singapore news, you can click here:
more Singapore newsFor more medical innovations news, you can click here:
more medical innovations newsFor more news from CNBC, you can click here:
more news from CNBCOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like medical innovations news, you might also like this article about
maternal deaths. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest medical devices news, care providers news, medical innovations news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
maternal careCNBC
•
86% Informative
Singapore -based startup Biorithm has developed a monitoring device that women can use to monitor their pregnancies at home.
The device, Femom , monitors both the maternal and fetal heart rate, and is designed to be simple to use.
A connected mobile app transmits information such as the baby's heart rate directly to clinicians .
VR Score
91
Informative language
92
Neutral language
84
Article tone
semi-formal
Language
English
Language complexity
51
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
2
Source diversity
1
Affiliate links
no affiliate links